Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
AssigneeAblynx N.V.
InventorsEdward Dolk, Michael John Scott Saunders, Hans De Haard
Life of this patent
Estimating the term…
Loading patent…
AssigneeAblynx N.V.
InventorsEdward Dolk, Michael John Scott Saunders, Hans De Haard
Estimating the term…
The present invention relates to amino acid sequences that are directed against (as defined herein) receptors for proteins with an immunoglobulin fold (Fc receptors), as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid sequences and polypeptides; to host cells expressing or capable of expressing such amino acid sequences or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such amino acid sequences, polypeptides, nucleic acids and/or host cells; and to uses of such amino acid sequences or polypeptides, nucleic acids, host cells and/or compositions, in particular for prophylactic, therapeutic or diagnostic puiposes, such as the prophylactic, therapeutic or diagnostic purposes mentioned herein.
Single variable domain that is directed against and/or that can specifically bind to an Fc receptor.
-4. (canceled)
-14. (canceled)
-18. (canceled)
(canceled)
-26. (canceled)
(canceled)
(canceled)
(canceled)
-48. (canceled)
(canceled)
-53. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.